What is the fine-grained topic of the following text: Prior to Relay, Jakob was a Founding Scientist of Syros Pharmaceuticals (NASDAQ: SYRS), which was founded on his co-discoveries in gene regulation sciences and technologies, and had its initial public offering in July 2016. Only return the topic.
Jakob's role in the foundation and early discoveries of Syros Pharmaceuticals.